Black Rock Inc. Guardant Health, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,237,856 shares of GH stock, worth $364 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,237,856
Previous 11,013,932
2.03%
Holding current value
$364 Million
Previous $227 Million
42.84%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding GH
# of Institutions
324Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$379 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$328 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$224 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$194 Million5.07% of portfolio
-
Baillie Gifford & CO5.87MShares$190 Million0.1% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.31B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...